-+ 0.00%
-+ 0.00%
-+ 0.00%

Jasper Therapeutics names Greg Keenan as chief medical officer in initial beneficial ownership filing

PUBT·07/23/2026 20:01:55
Listen to the news
Jasper Therapeutics names Greg Keenan as chief medical officer in initial beneficial ownership filing
  • Jasper Therapeutics Chief Medical Officer Greg Keenan disclosed stock options for 103,204 shares of voting common stock at $0.01.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-080864), on July 23, 2026, and is solely responsible for the information contained therein.